お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
680073

フローサイトメトリー市場:技術別、製品別、用途別、エンドユーザー別(病院、診断試験所、学術研究機関、その他):世界の業界見通し、包括的分析、予測

Flow Cytometry Market by Technology, by, Product, by application and by End User for Hospitals & Diagnostic Labs, Academic and Research Institutions and Others: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023

出版日: | 発行: Zion Market Research | ページ情報: 英文 110 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.68円
フローサイトメトリー市場:技術別、製品別、用途別、エンドユーザー別(病院、診断試験所、学術研究機関、その他):世界の業界見通し、包括的分析、予測
出版日: 2018年04月03日
発行: Zion Market Research
ページ情報: 英文 110 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のフローサイトメトリー市場について調査し、市場の現状と今後の成長予測、技術別、製品別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場動向

  • イントロダクション
  • 市場促進因子
  • 市場阻害因子
  • 機会
  • ポーターズファイブフォース分析
  • 市場の魅力度分析

第4章 競合環境

  • 企業市場シェア分析
  • 戦略的発展
  • 価格動向分析

第5章 技術別セグメント分析

  • 概要
  • セルベース
  • ビーズベース

第6章 製品分析

  • 概要
  • 試薬・消耗品
  • 計器
  • ソフトウェア
  • その他

第7章 用途別セグメント分析

  • 概要
  • 医薬品・創薬
  • 診断
  • その他

第8章 エンドユーザー別セグメント分析

  • 概要
  • 病院診断試験所
  • 学術研究機関
  • その他

第9章 地域別セグメント分析

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 企業プロファイル

目次

The report covers forecast and analysis for the flow cytometry market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2023 based revenue (USD Million). The study includes drivers and restraints for the flow cytometry market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the flow cytometry market on a global level. In order to give the users of this report a comprehensive view of the flow cytometry market, we have included competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein technology segment, product segment, application segment and end-user segment are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new technology launch, agreements, partnerships, collaborations joint ventures, research development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view on the flow cytometry market by segmenting the market based on technology, product, application, by end user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2023. Based on technology the market is segmented into cell-based and bead-based. Based on the product the market is segmented into reagents and consumables, instruments, software. Based on the application the market is segmented into pharmaceutical and drug discovery, diagnostics and others category. Based on end users the market is segmented into hospitals diagnostic labs, academic and research institutions and others category. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East Africa with its further bifurcation into major countries. This segmentation includes demand for flow cytometry market based on technology, product, its applications and end users in all the regions and countries.

The report also includes detailed profiles of end players such as Becton, Dickinson and Company, Merck Co., Inc., Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Sysmex Corporation, Alere, Inc., Miltenyi Biotec, Agilent Technologies, Inc., Bio-Techne, Bio-Rad Laboratories, Inc., and Others.

This report segments the global flow cytometry market as follows:

Global Flow Cytometry Market: Technology Segment Analysis

  • Cell-based
  • Bead-based

Global Flow Cytometry Market: Product Segment Analysis

  • Reagents and Consumables
  • Instruments
  • Software

Global Flow Cytometry Market: Application Segment Analysis

  • Pharmaceutical and Drug Discovery
  • Diagnostics
  • Others

Global Flow Cytometry Market: End User Method Analysis

  • Hospitals Diagnostic Labs
  • Academic and Research Institutions
  • Others

Global Flow Cytometry Market: Regional Segment Analysis

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa

Table Of Contents

Chapter 1. Introduction

  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology

Chapter 2. Executive Summary

  • 2.1. Global flow cytometry market, 2017 - 2023 (USD Million)
  • 2.2. Global flow cytometry market: snapshot

Chapter 3. Flow Cytometry Market- Market Dynamics

  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Global flow cytometry market drivers: impact analysis
    • 3.2.2. Rising incidences of HIV and cancer
    • 3.2.3. Technological advancements
  • 3.3. Market Restraints
    • 3.3.1. Global flow cytometry market restraints: impact analysis
    • 3.3.2. The high cost of the instrument
    • 3.3.3. Limited technical expertise
  • 3.4. Opportunities
    • 3.4.1. Emerging role of flow cytometry in drug discovery and development
  • 3.5. Porters five forces analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. The threat of new entrants
    • 3.5.4. The threat of new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market attractiveness analysis, by technology segment
    • 3.6.2. Market attractiveness analysis, by product segment
    • 3.6.3. Market attractiveness analysis, by application segment
    • 3.6.4. Market attractiveness analysis, by end user segment
    • 3.6.5. Market attractiveness analysis, by regional segment

Chapter 4. Global Flow Cytometry Market- Competitive Landscape

  • 4.1. Company market share analysis
    • 4.1.1. Global flow cytometry market: company market share, 2017
  • 4.2. Strategic development
    • 4.2.1. Acquisitions mergers
    • 4.2.2. New therapy launch
    • 4.2.3. Agreements, partnerships, collaborations and joint ventures
    • 4.2.4. Research and development and regional expansion
  • 4.3. Price trend analysis

Chapter 5. Global Flow Cytometry Market- Technology Segment Analysis

  • 5.1. Global flow cytometry market: Technology type overview
    • 5.1.1. Global flow cytometry market revenue share, by technology, 2017 and 2023
  • 5.2. Cell-based
    • 5.2.1. Global flow cytometry market for cell-based, 2017 - 2023 (USD Million)
  • 5.3. Bead-based
    • 5.3.1. Global flow cytometry market for bead-based, 2017 - 2023 (USD Million)

Chapter 6. Global Flow Cytometry Market- Product Analysis

  • 6.1. Global flow cytometry market: Product type overview
    • 6.1.1. Global flow cytometry market revenue share, by product, 2017 and 2023
  • 6.2. Reagents and Consumables
    • 6.2.1. Global flow cytometry market for reagents and consumables, 2017 - 2023 (USD Million)
  • 6.3. Instruments
    • 6.3.1. Global flow cytometry market for instruments, 2017 - 2023 (USD Million)
  • 6.4. Software
    • 6.4.1. Global flow cytometry market for software, 2017 - 2023 (USD Million)

Chapter 7. Global Flow Cytometry Market- Application Analysis

  • 7.1. Global flow cytometry market: Application type overview
    • 7.1.1. Global flow cytometry market revenue share, by product, 2017 and 2023
  • 7.2. Pharmaceutical and Drug Discovery
    • 7.2.1. Global flow cytometry market for pharmaceutical and drug Discovery, 2017 - 2023 (USD Million)
  • 7.3. Diagnostics
    • 7.3.1. Global flow cytometry market for diagnostics, 2017 - 2023 (USD Million)
  • 7.4. Others
    • 7.4.1. Global flow cytometry market for others, 2017 - 2023 (USD Million)

Chapter 8. Global Flow Cytometry Market- End User Analysis

  • 8.1. Global flow cytometry market: End user type overview
    • 8.1.1. Global flow cytometry market revenue share, by product, 2017 and 2023
  • 8.2. Hospitals Diagnostic Labs
    • 8.2.1. Global flow cytometry market for hospitals diagnostic labs, 2017 - 2023 (USD Million)
  • 8.3. Academic and Research Institutions
    • 8.3.1. Global flow cytometry market for academic and research institutions, 2017 - 2023 (USD Million)
  • 8.4. Others
    • 8.4.1. Global flow cytometry market for others, 2017 - 2023 (USD Million)

Chapter 9. Global Flow Cytometry Market- Regional Segment Analysis

  • 9.1. Global flow cytometry market: regional overview
    • 9.1.1. Global flow cytometry market revenue share, by region, 2017 and 2023
  • 9.2. North America
    • 9.2.1. North America flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
    • 9.2.2. North America flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
    • 9.2.3. North America flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
    • 9.2.4. North America flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
    • 9.2.5. U.S.
      • 9.2.5.1. U.S. flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
      • 9.2.5.2. U.S. flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
      • 9.2.5.3. U.S. flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
      • 9.2.5.4. U.S. flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
    • 9.2.6. Rest of North America
      • 9.2.6.1. Rest of North America flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
      • 9.2.6.2. Rest of North America flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
      • 9.2.6.3. Rest of North America flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
      • 9.2.6.4. Rest of North America flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
    • 9.3.2. Europe flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
    • 9.3.3. Europe flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
    • 9.3.4. Europe flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
    • 9.3.5. U.K.
      • 9.3.5.1. U.K. flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
      • 9.3.5.2. U.K. flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
      • 9.3.5.3. U.K. flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
      • 9.3.5.4. U.K. flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
    • 9.3.6. Germany
      • 9.3.6.1. Germany flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
      • 9.3.6.2. Germany flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
      • 9.3.6.3. Germany flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
      • 9.3.6.4. Germany flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
    • 9.3.7. France
      • 9.3.7.1. France flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
      • 9.3.7.2. France flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
      • 9.3.7.3. France flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
      • 9.3.7.4. France flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
    • 9.3.8. Rest of Europe
      • 9.3.8.1. Rest of Europe flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
      • 9.3.8.2. Rest of Europe flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
      • 9.3.8.3. Rest of Europe flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
      • 9.3.8.4. Rest of Europe flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
    • 9.4.2. Asia Pacific flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
    • 9.4.3. Asia Pacific flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
    • 9.4.4. Asia Pacific flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
    • 9.4.5. China
      • 9.4.5.1. China flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
      • 9.4.5.2. China flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
      • 9.4.5.3. China flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
      • 9.4.5.4. China flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
    • 9.4.6. Japan
      • 9.4.6.1. Japan flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
      • 9.4.6.2. Japan flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
      • 9.4.6.3. Japan flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
      • 9.4.6.4. Japan flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
    • 9.4.7. India
      • 9.4.7.1. India flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
      • 9.4.7.2. India flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
      • 9.4.7.3. India flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
      • 9.4.7.4. India flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
    • 9.4.8. Rest of Asia Pacific
      • 9.4.8.1. Rest of Asia Pacific flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
      • 9.4.8.2. Rest of Asia Pacific flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
      • 9.4.8.3. Rest of Asia Pacific flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
      • 9.4.8.4. Rest of Asia Pacific flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
    • 9.5.2. Latin America flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
    • 9.5.3. Latin America flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
    • 9.5.4. Latin America flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
    • 9.5.5. Brazil
      • 9.5.5.1. Brazil flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
      • 9.5.5.2. Brazil flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
      • 9.5.5.3. Brazil flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
      • 9.5.5.4. Brazil flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
    • 9.5.6. Rest of Latin America
      • 9.5.6.1. Rest of Latin America flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
      • 9.5.6.2. Rest of Latin America flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
      • 9.5.6.3. Rest of Latin America flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
      • 9.5.6.4. Rest of Latin America flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa flow cytometry market revenue, by technology, 2017 - 2023 (USD Million)
    • 9.6.2. Middle East and Africa flow cytometry market revenue, by product, 2017 - 2023 (USD Million)
    • 9.6.3. Middle East and Africa flow cytometry market revenue, by application, 2017 - 2023 (USD Million)
    • 9.6.4. Middle East and Africa flow cytometry market revenue, by end user, 2017 - 2023 (USD Million)

Chapter 10. Company Profiles

  • 10.1. Becton, Dickinson and Company
    • 10.1.1. Overview
    • 10.1.2. Financials
    • 10.1.3. Therapy portfolio
    • 10.1.4. Business strategy
    • 10.1.5. Recent developments
  • 10.2. Merck Co., Inc.
    • 10.2.1. Overview
    • 10.2.2. Financials
    • 10.2.3. Therapy portfolio
    • 10.2.4. Business strategy
    • 10.2.5. Recent developments
  • 10.3. Beckman Coulter, Inc.
    • 10.3.1. Overview
    • 10.3.2. Financials
    • 10.3.3. Therapy portfolio
    • 10.3.4. Business strategy
    • 10.3.5. Recent developments
  • 10.4. Thermo Fisher Scientific, Inc.
    • 10.4.1. Overview
    • 10.4.2. Financials
    • 10.4.3. Therapy portfolio
    • 10.4.4. Business strategy
    • 10.4.5. Recent developments
  • 10.5. Sysmex Corporation
    • 10.5.1. Overview
    • 10.5.2. Financials
    • 10.5.3. Therapy portfolio
    • 10.5.4. Business strategy
    • 10.5.5. Recent developments
  • 10.6. Alere Inc.
    • 10.6.1. Overview
    • 10.6.2. Financials
    • 10.6.3. Therapy portfolio
    • 10.6.4. Business strategy
    • 10.6.5. Recent developments
  • 10.7. Miltenyi Biotec
    • 10.7.1. Overview
    • 10.7.2. Financials
    • 10.7.3. Therapy portfolio
    • 10.7.4. Business strategy
    • 10.7.5. Recent developments
  • 10.8. Agilent Technologies, Inc.
    • 10.8.1. Overview
    • 10.8.2. Financials
    • 10.8.3. Therapy portfolio
    • 10.8.4. Business strategy
    • 10.8.5. Recent developments
  • 10.9. Bio-Techne
    • 10.9.1. Overview
    • 10.9.2. Financials
    • 10.9.3. Therapy portfolio
    • 10.9.4. Business strategy
    • 10.9.5. Recent developments
  • 10.10. Bio-Rad Laboratories, Inc.
    • 10.10.1. Overview
    • 10.10.2. Financials
    • 10.10.3. Therapy portfolio
    • 10.10.4. Business strategy
    • 10.10.5. Recent developments
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.